Clinical trial
SLPI: a Novel Biomarker of Prostate Cancer
NCT04854343 is registered in ClinicalTrials.gov with University of Florence as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- SLPI: a Novel Biomarker of Prostate Cancer
- Lead sponsor
- University of Florence
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- December 1, 2020
- Completion date
- July 1, 2024
- Enrollment
- 280 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
prostate cancer, prostatic neoplasm